Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men (2012)
- Authors:
- Lu, Beibei
- Viscidi, Raphael P.
- Wu, Yougui
- Lee, Ji-Hyun
- Nyitray, Alan G.
- Villa, Luisa L.
- Lazcano-Ponce, Eduardo - Instituto Nacional de Salud Pública (INSP-MX)
- Silva, Roberto J. Carvalho da
- Baggio, Maria Luiza
- Quiterio, Manuel - Instituto Nacional de Salud Pública (INSP-MX)
- Salmeron, Jorge
- Smith, Danelle C.
- Abrahamsen, Martha E.
- Papenfuss, Mary R.
- Stockwell, Heather G.
- Giuliano, Anna R.
- Autor USP: VILLA, LUISA LINA - FM
- Unidade: FM
- DOI: 10.1158/0008-5472.CAN-11-0751
- Subjects: VACINAS VIRAIS; IMUNIZAÇÃO; ONCOGENES; NEOPLASIAS DO COLO UTERINO; ANTICORPOS; BIOMARCADORES; HPV (IMUNOLOGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 72, n. 3, p. 676-685, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
LU, Beibei et al. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Research, v. 72, n. 3, p. 676-685, 2012Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.CAN-11-0751. Acesso em: 19 set. 2024. -
APA
Lu, B., Viscidi, R. P., Wu, Y., Lee, J. -H., Nyitray, A. G., Villa, L. L., et al. (2012). Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men. Cancer Research, 72( 3), 676-685. doi:10.1158/0008-5472.CAN-11-0751 -
NLM
Lu B, Viscidi RP, Wu Y, Lee J-H, Nyitray AG, Villa LL, Lazcano-Ponce E, Silva RJC da, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen ME, Papenfuss MR, Stockwell HG, Giuliano AR. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men [Internet]. Cancer Research. 2012 ; 72( 3): 676-685.[citado 2024 set. 19 ] Available from: https://doi.org/10.1158/0008-5472.CAN-11-0751 -
Vancouver
Lu B, Viscidi RP, Wu Y, Lee J-H, Nyitray AG, Villa LL, Lazcano-Ponce E, Silva RJC da, Baggio ML, Quiterio M, Salmeron J, Smith DC, Abrahamsen ME, Papenfuss MR, Stockwell HG, Giuliano AR. Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in Men [Internet]. Cancer Research. 2012 ; 72( 3): 676-685.[citado 2024 set. 19 ] Available from: https://doi.org/10.1158/0008-5472.CAN-11-0751 - Sobre a acao do cloridrato de guanidina na inducao de mutantes 'RO IND.-' Em saccharomyces cerevisiae
- Association Between HPV Types and Species Groups and Cervical Neoplasia From a High-risk Area for Cervical Cancer, Goiania, Brazil
- Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection
- Identificação do papilomavírus humano em doentes com carcinoma de células escamosas do canal anal e sua relação com o grau de diferenciação celular e estadiamento
- Association of chlamydia trachomatis infection and herpes simplex virus type 2 serostatus with genital human papillomavirus infection in men: The HPV in men study
- Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study
- Human papillomavirus virus (HPV) genotype and age-specific analysis of external genital lesions among men in the HPV infection in men (HIM) study
- Role of histological findings and pathologic diagnosis for detection of human papillomavirus infection in men
- HPV infection and cervical neoplasia: associated risk factors
- Diversity of beta-papillomavirus at anogenital and oral anatomic sites of men: The HIM Study
Informações sobre o DOI: 10.1158/0008-5472.CAN-11-0751 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
